Ann: Trading Halt, page-280

First 280 Last

Share
Profile

Follow
pintohoo

86,967 Posts.

75

08/12/17

15:01

Post #: 29489522
Share

Originally posted by joewolf ↑

Pinto - I respect your views. You seem to be implying that you have seen the term sheet. I have not been able to locate the broker handling it but must also admit I have not gone out of my way to find them as I am concerned that I may well be in the boat as all other "mugs" on this one... I won't take any more until my trust is restored - so in good conscience, I am loathe to ask for the term sheet.

If you have had access to the term sheets - they are in fact confidential and as I get them occasionally you are required not to forward them or have to agree not to disclose them. However, as I understand it you can at least hint...

Personally - I won't invest in companies with certain directors - Had I looked at AJX today it would fall into the camp of a company I would not invest in. Read between the lines - D13 would also be in that camp...

However, you could at least give us all a hint about how big and how big a discount ...

Right now it's useless for us to try to engage with you as you seem to have more info then we do.

Personally, I am extremely concerned about what is happening here and I cannot believe this trading halt... I think that if it's just another raising the ASX / ASIC needs to be engaged in this - I cannot believe it is as the new directors must be uncomfortable after what was said and recorded at the AGM.

Expand

yup

I would like to continue the conversation perhaps later next year

AJX Price at posting: 38.0¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

There are more pages in this discussion • 95 more messages in this thread...

First 280 Last

Add AJX (ASX) to my watchlist

(20min delay)
Last 1.3¢		Change 0.000(0.00%)		Mkt cap ! $20.46M

Open	High	Low	Value	Volume
1.4¢	1.4¢	1.3¢	$2.2K	157.6K

Buyers (Bids)

No.	Vol.	Price($)
1	42000	1.2¢

Sellers (Offers)

Price($)	Vol.	No.
1.5¢	906200	4

View Market Depth

No.	Vol.	Price($)
1	42000	0.012
3	4058332	0.010
5	2072715	0.009
3	1186222	0.008
2	240000	0.007

Price($)	Vol.	No.
0.015	906200	4
0.016	429958	1
0.017	321118	2
0.018	115942	2
0.019	12500	1

Last trade - 14.20pm 07/10/2024 (20 minute delay)

AJX (ASX) Chart

Ann: Trading Halt, page-280

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Trading Halt, page-280

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News